Health
Botanix collab with UQ confirms antimicrobial potential of CBD – Stockhead
Botanix Pharmaceuticals shares are on the rise after research showed that a synthetic cannabidiol formulation can kill so-called “superbugs”.
Link copied toclipboard
BotanixPharmaceuticals (ASX:BOT) shares are on the rise this morning after research from the University of Queensland showed that a synthetic cannabidiol formulation can kill so-called “superbugs”, or gram-negative bacteria.
CBD can destroy the bacteria responsible for gonorrhoea, meningitis and legionnaire’s disease, according to the Botanix-backed article published today in the peer-reviewed journal Communications Biology.
“Our results demonstrate that cannabidiol has excellent…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News15 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout